Total planned funding: $259,291,662
Clear active filters
Implementing Agency
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| South Africa | $114,705,339 |
| Zimbabwe | $25,845,499 |
| Uganda | $25,025,984 |
| Ethiopia | $14,782,300 |
| Nigeria | $13,007,306 |
| Côte d'Ivoire | $10,746,616 |
| Kenya | $7,691,497 |
| Lesotho | $6,699,199 |
| Zambia | $6,631,079 |
| Cameroon | $6,460,175 |
| Mozambique | $5,753,109 |
| Tanzania | $4,329,776 |
| Dominican Republic | $4,259,442 |
| Ukraine | $2,600,000 |
| Malawi | $2,168,586 |
| Guyana | $1,900,000 |
| Ghana | $1,497,998 |
| Caribbean Region | $1,365,000 |
| Namibia | $1,233,682 |
| Vietnam | $1,038,075 |
| Indonesia | $650,000 |
| Botswana | $616,000 |
| Cambodia | $285,000 |
| Angola | $0 |
Organizational Types
| Implementing Agency | $259,291,662 |
Program Areas
| Treatment | $73,721,834 |
| Care | $66,915,487 |
| Prevention | $65,749,676 |
| Governance and Systems | $32,422,398 |
| Testing | $20,482,267 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $65,999,338 |
| HBHC: Care: Adult Care and Support | $27,689,125 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $22,163,262 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $21,931,654 |
| HKID: Care: Orphans and Vulnerable Children | $21,844,303 |
| HVCT: Testing: HIV Testing and Counseling | $20,482,267 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $15,116,488 |
| HVTB: Care: TB/HIV | $13,212,455 |
| OHSS: Health Systems Strengthening | $13,203,788 |
| HVSI: Strategic Information | $9,906,226 |
| HLAB: Laboratory Infrastructure | $9,312,384 |
| PDTX: Treatment: Pediatric Treatment | $6,816,283 |
| PDCS: Care: Pediatric Care and Support | $4,169,604 |
| HMBL: Biomedical Prevention: Blood Safety | $3,364,391 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $1,942,037 |
| HTXD: Treatment: ARV Drugs | $906,213 |
| HMIN: Biomedical Prevention: Injection Safety | $711,844 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $520,000 |
Top Partner Programs
University of the Witwatersrand:
$29,976,169
View countries